Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?

Hanan Goldberg, Rachel Glicksman, Dixon Woon, Ally Hoffman, Hina Shaikh, Thenappan Chandrasekar, Zachary Klaassen, Christopher J.D. Wallis, Ardalan E. Ahmad, Noelia Sanmamed-Salgado, Xuanlu Qu, Fabio Y. Moraes, Eleftherios P. Diamandis, Alejandro Berlin, Neil E. Fleshner

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?'. Together they form a unique fingerprint.

Medicine & Life Sciences